
2026 Horizons Life Sciences and Health Care

EU MedTech Horizons 2026

Market Access in Europe

EU moves to align Notified Bodies’ practices under the MDR and IVDR

How the EU Biotech Act aims to foster biotech innovation in Europe

FDA updates compliance program inspection manual for the QMSR age

FDA readies for QMSR implementation with draft QMS information guidance: What manufacturers need to know

FDA medical device inspections in 2025: What we're seeing, what we expected, and why you need the right expertise now

EU pilot programme for breakthrough medical devices: applications open
“Hogan Lovells” or the “firm” is an international legal practice that includes Hogan Lovells International LLP, Hogan Lovells US LLP and their affiliated businesses.
The word “partner” is used to describe a partner or member of Hogan Lovells International LLP, Hogan Lovells US LLP or any of their affiliated entities or any employee or consultant with equivalent standing. Certain individuals, who are designated as partners, but who are not members of Hogan Lovells International LLP, do not hold qualifications equivalent to members.
For more information about Hogan Lovells, the partners and their qualifications, see www.hoganlovells.com.
Where case studies are included, results achieved do not guarantee similar outcomes for other clients. Attorney advertising. Images of people may feature current or former lawyers and employees at Hogan Lovells or models not connectedwith the firm.
© Hogan Lovells 2026. All rights reserved. BT-REQ-4700
